BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schraivogel D, Weinmann L, Beier D, Tabatabai G, Eichner A, Zhu JY, Anton M, Sixt M, Weller M, Beier CP, Meister G. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. EMBO J 2011;30:4309-22. [PMID: 21857646 DOI: 10.1038/emboj.2011.301] [Cited by in Crossref: 111] [Cited by in F6Publishing: 107] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Mallik MK. An attempt to understand glioma stem cell biology through centrality analysis of a protein interaction network. Journal of Theoretical Biology 2018;438:78-91. [DOI: 10.1016/j.jtbi.2017.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kondo Y, Katsushima K, Ohka F, Natsume A, Shinjo K. Epigenetic dysregulation in glioma. Cancer Sci 2014;105:363-9. [PMID: 24843883 DOI: 10.1111/cas.12379] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
3 Jin D, Lee H. Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets. Sci Rep 2016;6:35350. [PMID: 27734929 DOI: 10.1038/srep35350] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
4 Zhang X, Zhu Y. Research Progress on Regulating LncRNAs of Hepatocellular Carcinoma Stem Cells. Onco Targets Ther 2021;14:917-27. [PMID: 33603396 DOI: 10.2147/OTT.S289064] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tan X, Wang S, Yang B, Zhu L, Yin B, Chao T, Zhao J, Yuan J, Qiang B, Peng X. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PLoS One 2012;7:e49570. [PMID: 23185366 DOI: 10.1371/journal.pone.0049570] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
6 Gomez GG, Volinia S, Croce CM, Zanca C, Li M, Emnett R, Gutmann DH, Brennan CW, Furnari FB, Cavenee WK. Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res 2014;74:1429-39. [PMID: 24436148 DOI: 10.1158/0008-5472.CAN-13-2117] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
7 Krell J, Stebbing J, Carissimi C, Dabrowska AF, de Giorgio A, Frampton AE, Harding V, Fulci V, Macino G, Colombo T, Castellano L. TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network. Genome Res 2016;26:331-41. [PMID: 26701625 DOI: 10.1101/gr.191759.115] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
8 Kim DY, Hwang I, Muller FL, Paik JH. Functional regulation of FoxO1 in neural stem cell differentiation. Cell Death Differ 2015;22:2034-45. [PMID: 26470727 DOI: 10.1038/cdd.2015.123] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
9 Takahashi RU, Miyazaki H, Ochiya T. The role of microRNAs in the regulation of cancer stem cells. Front Genet. 2014;4:295. [PMID: 24427168 DOI: 10.3389/fgene.2013.00295] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 10.8] [Reference Citation Analysis]
10 Costa PM, Cardoso AL, Pereira de Almeida LF, Bruce JN, Canoll P, Pedroso de Lima MC. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. Hum Mol Genet 2012;21:5118-30. [PMID: 22922228 DOI: 10.1093/hmg/dds358] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
11 Liao H, Liao M, Xu L, Yan X, Ren B, Zhu Z, Yuan K, Zeng Y. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine 2019;41:310-9. [PMID: 30665854 DOI: 10.1016/j.ebiom.2019.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Paulmurugan R, Malhotra M, Massoud TF. The protean world of non-coding RNAs in glioblastoma. J Mol Med (Berl) 2019;97:909-25. [PMID: 31129756 DOI: 10.1007/s00109-019-01798-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Front Cell Neurosci 2013;7:220. [PMID: 24312010 DOI: 10.3389/fncel.2013.00220] [Cited by in Crossref: 162] [Cited by in F6Publishing: 152] [Article Influence: 18.0] [Reference Citation Analysis]
14 Ames H, Halushka MK, Rodriguez FJ. miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications. J Neuropathol Exp Neurol 2017;76:246-54. [PMID: 28431179 DOI: 10.1093/jnen/nlx005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
15 Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, Li W, Hu B, Cheng SY, Li M. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 2013;73:990-999. [PMID: 23204229 DOI: 10.1158/0008-5472.can-12-2895] [Cited by in Crossref: 100] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
16 Zang L, Kondengaden SM, Che F, Wang L, Heng X. Potential Epigenetic-Based Therapeutic Targets for Glioma. Front Mol Neurosci 2018;11:408. [PMID: 30498431 DOI: 10.3389/fnmol.2018.00408] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
17 Li Q, Chang Y, Mu L, Song Y. MicroRNA-9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF-κB signaling pathway. Oncol Lett 2019;17:4819-26. [PMID: 31186688 DOI: 10.3892/ol.2019.10158] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Shah V, Shah J. Recent trends in targeting miRNAs for cancer therapy. J Pharm Pharmacol 2020;72:1732-49. [PMID: 32783235 DOI: 10.1111/jphp.13351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Vira D, Basak SK, Veena MS, Wang MB, Batra RK, Srivatsan ES. Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer Metastasis Rev. 2012;31:733-751. [PMID: 22752409 DOI: 10.1007/s10555-012-9382-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
20 Yang HW, Xing H, Johnson MD. A major role for microRNAs in glioblastoma cancer stem-like cells. Arch Pharm Res 2015;38:423-34. [PMID: 25683176 DOI: 10.1007/s12272-015-0574-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
21 Coolen M, Bally-Cuif L. [miR-9: a key factor of the physiopathological regulation of the neural progenitor state]. Med Sci (Paris) 2013;29:1010-7. [PMID: 24280505 DOI: 10.1051/medsci/20132911018] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Kania EE, Carvajal-Moreno J, Hernandez VA, English A, Papa JL, Shkolnikov N, Ozer HG, Yilmaz AS, Yalowich JC, Elton TS. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase IIα in Human Leukemia K562 Cells with Acquired Resistance to Etoposide. Mol Pharmacol 2020;97:159-70. [PMID: 31836624 DOI: 10.1124/mol.119.118315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012;19:723-730. [PMID: 22975591 DOI: 10.1038/cgt.2012.58] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
24 He Z, Yang C, He Y, Gong B, Yin C, Feng J, Chen L, Tang J, Chen Y. CAMTA1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation. Cell Signal 2021;79:109882. [PMID: 33316386 DOI: 10.1016/j.cellsig.2020.109882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Shan F, Li J, Huang QY. HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia. J Cell Physiol 2014;229:1511-20. [PMID: 24615545 DOI: 10.1002/jcp.24593] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
26 Lamar JM, Motilal Nehru V, Weinberg G. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma. Cancers (Basel) 2018;10:E229. [PMID: 29996478 DOI: 10.3390/cancers10070229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
27 Berchtold MW, Villalobo A. The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer. Biochim Biophys Acta 2014;1843:398-435. [PMID: 24188867 DOI: 10.1016/j.bbamcr.2013.10.021] [Cited by in Crossref: 171] [Cited by in F6Publishing: 165] [Article Influence: 19.0] [Reference Citation Analysis]
28 Ghosh S, Kumar V, Mukherjee H, Lahiri D, Roy P. Nutraceutical regulation of miRNAs involved in neurodegenerative diseases and brain cancers. Heliyon 2021;7:e07262. [PMID: 34195404 DOI: 10.1016/j.heliyon.2021.e07262] [Reference Citation Analysis]
29 Sana J, Busek P, Fadrus P, Besse A, Radova L, Vecera M, Reguli S, Stollinova Sromova L, Hilser M, Lipina R, Lakomy R, Kren L, Smrcka M, Sedo A, Slaby O. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sci Rep 2018;8:2836. [PMID: 29434344 DOI: 10.1038/s41598-018-20929-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
30 Nowek K, Sun SM, Bullinger L, Bindels EM, Exalto C, Dijkstra MK, van Lom K, Döhner H, Erkeland SJ, Löwenberg B, Jongen-Lavrencic M. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG. Leukemia 2016;30:229-37. [PMID: 26174629 DOI: 10.1038/leu.2015.183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
31 Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y, Liang Z, Yuan F, Liu J, Wang J, Zheng Y, Dong D, Bian S, Yang B, Jiang C, Li Q. MicroRNA-300 inhibited glioblastoma progression through ROCK1. Oncotarget 2016;7:36529-38. [PMID: 27145462 DOI: 10.18632/oncotarget.9068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
32 Toraih EA, Aly NM, Abdallah HY, Al-Qahtani SA, Shaalan AA, Hussein MH, Fawzy MS. MicroRNA-target cross-talks: Key players in glioblastoma multiforme. Tumour Biol 2017;39:1010428317726842. [PMID: 29110584 DOI: 10.1177/1010428317726842] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
33 Yan H, Bu P. Non-coding RNAs in cancer stem cells. Cancer Letters 2018;421:121-6. [DOI: 10.1016/j.canlet.2018.01.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
34 Mondal I, Sharma S, Kulshreshtha R. MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 261-92. [DOI: 10.1016/b978-0-12-815669-8.00010-5] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Zottel A, Šamec N, Kump A, Raspor Dall'Olio LR, Pužar Dominkuš P, Romih R, Hudoklin S, Mlakar J, Nikitin D, Sorokin M, Buzdin A, Jovčevska I, Komel R. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles. Int J Mol Sci 2020;21:E8491. [PMID: 33187334 DOI: 10.3390/ijms21228491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Møller HG, Rasmussen AP, Andersen HH, Johnsen KB, Henriksen M, Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol. 2013;47:131-144. [PMID: 23054677 DOI: 10.1007/s12035-012-8349-7] [Cited by in Crossref: 171] [Cited by in F6Publishing: 162] [Article Influence: 17.1] [Reference Citation Analysis]
37 Ben-Hamo R, Zilberberg A, Cohen H, Efroni S. hsa-miR-9 controls the mobility behavior of glioblastoma cells via regulation of MAPK14 signaling elements. Oncotarget 2016;7:23170-81. [PMID: 27036038 DOI: 10.18632/oncotarget.6687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
38 Deng Y, Zhu G, Luo H, Zhao S. MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells. Mol Cells 2016;39:619-24. [PMID: 27484906 DOI: 10.14348/molcells.2016.0118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, Loffredo CA, Zheng YL. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One. 2012;7:e39011. [PMID: 22723919 DOI: 10.1371/journal.pone.0039011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
40 Yang Y, Ren M, Song C, Li D, Soomro SH, Xiong Y, Zhang H, Fu H. LINC00461, a long non-coding RNA, is important for the proliferation and migration of glioma cells. Oncotarget 2017;8:84123-39. [PMID: 29137410 DOI: 10.18632/oncotarget.20340] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
41 Thompson MJ, Rubbi L, Dawson DW, Donahue TR, Pellegrini M. Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes. PLoS One 2015;10:e0128814. [PMID: 26039411 DOI: 10.1371/journal.pone.0128814] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
42 Balaraman S, Winzer-Serhan UH, Miranda RC. Opposing actions of ethanol and nicotine on microRNAs are mediated by nicotinic acetylcholine receptors in fetal cerebral cortical-derived neural progenitor cells. Alcohol Clin Exp Res 2012;36:1669-77. [PMID: 22458409 DOI: 10.1111/j.1530-0277.2012.01793.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
43 Khafaei M, Rezaie E, Mohammadi A, Shahnazi Gerdehsang P, Ghavidel S, Kadkhoda S, Zorrieh Zahra A, Forouzanfar N, Arabameri H, Tavallaie M. miR-9: From function to therapeutic potential in cancer. J Cell Physiol 2019. [PMID: 30693512 DOI: 10.1002/jcp.28210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
44 Godlewski J, Lenart J, Salinska E. MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer. Noncoding RNA 2019;5:E20. [PMID: 30813461 DOI: 10.3390/ncrna5010020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
45 Ottaviani S, Stebbing J, Frampton AE, Zagorac S, Krell J, de Giorgio A, Trabulo SM, Nguyen VTM, Magnani L, Feng H, Giovannetti E, Funel N, Gress TM, Jiao LR, Lombardo Y, Lemoine NR, Heeschen C, Castellano L. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nat Commun 2018;9:1845. [PMID: 29748571 DOI: 10.1038/s41467-018-03962-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
46 Chu PM, Ma HI, Chen LH, Chen MT, Huang PI, Lin SZ, Chiou SH. Deregulated microRNAs identified in isolated glioblastoma stem cells: an overview. Cell Transplant 2013;22:741-53. [PMID: 23127968 DOI: 10.3727/096368912X655190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ogata K, Sumida K, Miyata K, Kushida M, Kuwamura M, Yamate J. Circulating miR-9* and miR-384-5p as potential indicators for trimethyltin-induced neurotoxicity. Toxicol Pathol 2015;43:198-208. [PMID: 24777749 DOI: 10.1177/0192623314530533] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
48 Ali Hosseini Rad SM, Bavarsad MS, Arefian E, Jaseb K, Shahjahani M, Saki N. The Role of microRNAs in Stemness of Cancer Stem Cells. Oncol Rev 2013;7:e8. [PMID: 25992229 DOI: 10.4081/oncol.2013.e8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
49 Gao X, Mi Y, Guo N, Xu H, Jiang P, Zhang R, Xu L, Gou X. Glioma in Schizophrenia: Is the Risk Higher or Lower? Front Cell Neurosci 2018;12:289. [PMID: 30233327 DOI: 10.3389/fncel.2018.00289] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Zhang A, Hao J, Wang K, Huang Q, Yu K, Kang C, Wang G, Jia Z, Han L, Pu P. Down-regulation of miR-106b suppresses the growth of human glioma cells. J Neurooncol 2013;112:179-89. [PMID: 23377830 DOI: 10.1007/s11060-013-1061-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
51 Karunanithi S, Levi L, DeVecchio J, Karagkounis G, Reizes O, Lathia JD, Kalady MF, Noy N. RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis. Stem Cell Reports 2017;9:438-50. [PMID: 28689994 DOI: 10.1016/j.stemcr.2017.06.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
52 Zhou L, Zang G, Zhang G, Wang H, Zhang X, Johnston N, Min W, Luke P, Jevnikar A, Haig A, Zheng X. MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation. PLoS One 2013;8:e79805. [PMID: 24278182 DOI: 10.1371/journal.pone.0079805] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
53 Hayes J, Thygesen H, Droop A, Hughes TA, Westhead D, Lawler SE, Wurdak H, Short SC. Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation. Oncoscience 2015;2:252-62. [PMID: 25897422 DOI: 10.18632/oncoscience.112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Cancer cells stemness: A doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 2019;pii:S0925-4439(19)30071-7. [PMID: 30818002 DOI: 10.1016/j.bbadis.2019.02.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
55 Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST, Bigner DD, Li QJ, Wang H, Wang XF. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J Clin Invest 2014;124:4489-502. [PMID: 25202981 DOI: 10.1172/JCI75284] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
56 Koshkin FA, Chistyakov DA, Nikitin AG, Konovalov AN, Potapov AA, Usachyov DY, Pitskhelauri DI, Kobyakov GL, Shishkina LV, Chekhonin VP. Profile of microRNA expression in brain tumors of different malignancy. Bull Exp Biol Med 2014;157:794-7. [PMID: 25348569 DOI: 10.1007/s10517-014-2669-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
57 Li W, Cui Y, Ma W, Wang M, Cai Y, Jiang Y. LncRNA RBPMS-AS1 promotes NRGN transcription to enhance the radiosensitivity of glioblastoma through the microRNA-301a-3p/CAMTA1 axis. Transl Oncol 2021;15:101282. [PMID: 34800915 DOI: 10.1016/j.tranon.2021.101282] [Reference Citation Analysis]
58 Ao R, Wang Y, Tong J, Wang BF. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Med Sci Monit. 2016;22:3804-3819. [PMID: 27756894 DOI: 10.12659/msm.897207] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
59 Tanas MR, Ma S, Jadaan FO, Ng CK, Weigelt B, Reis-Filho JS, Rubin BP. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2016;35:929-938. [PMID: 25961935 DOI: 10.1038/onc.2015.148] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
60 Nowek K, Wiemer EAC, Jongen-Lavrencic M. The versatile nature of miR-9/9* in human cancer. Oncotarget 2018;9:20838-54. [PMID: 29755694 DOI: 10.18632/oncotarget.24889] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
61 Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S, Jacoby E, Yalon M, Toren A, Mikkelsen T, Brodie C. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 2013;4:665-76. [PMID: 23714687 DOI: 10.18632/oncotarget.928] [Cited by in Crossref: 137] [Cited by in F6Publishing: 135] [Article Influence: 17.1] [Reference Citation Analysis]
62 Cao F, Zhang Q, Chen W, Zheng F, Ran Q, He Y, Gao Y, Yao S. miR-6743-5p, as a direct upstream regulator of GRIM-19, enhances proliferation and suppresses apoptosis in glioma cells. Biosci Rep 2017;37:BSR20171038. [PMID: 29074558 DOI: 10.1042/BSR20171038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Gao X, Jin W. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett 2014;353:25-31. [PMID: 25042866 DOI: 10.1016/j.canlet.2014.07.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
64 Yang L, Mu Y, Cui H, Liang Y, Su X. MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma. PLoS One 2017;12:e0174839. [PMID: 28430789 DOI: 10.1371/journal.pone.0174839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
65 Sugita F, Maki K, Nakamura Y, Sasaki K, Mitani K. Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia. Leuk Lymphoma 2014;55:78-86. [PMID: 23547834 DOI: 10.3109/10428194.2013.790023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
66 Henriksen M, Johnsen KB, Andersen HH, Pilgaard L, Duroux M. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. Mol Neurobiol 2014;50:896-913. [PMID: 24619503 DOI: 10.1007/s12035-014-8668-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
67 Short SC. Science in Focus: MicroRNA in Glioma - Potential as Biomarkers and Therapeutic Targets. Clin Oncol (R Coll Radiol) 2016;28:543-6. [PMID: 27184942 DOI: 10.1016/j.clon.2016.04.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Pecce V, Verrienti A, Fiscon G, Sponziello M, Conte F, Abballe L, Durante C, Farina L, Filetti S, Paci P. The role of FOSL1 in stem-like cell reprogramming processes. Sci Rep 2021;11:14677. [PMID: 34282187 DOI: 10.1038/s41598-021-94072-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ. Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Front Genet 2012;3:323. [PMID: 23335942 DOI: 10.3389/fgene.2012.00323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
70 Garg N, Vijayakumar T, Bakhshinyan D, Venugopal C, Singh SK. MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours. Stem Cells Int 2015;2015:141793. [PMID: 26064134 DOI: 10.1155/2015/141793] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
71 Mikami J, Kurokawa Y, Takahashi T, Miyazaki Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study. Gastric Cancer. 2016;19:817-826. [PMID: 26486505 DOI: 10.1007/s10120-015-0556-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
72 Katsushima K, Shinjo K, Natsume A, Ohka F, Fujii M, Osada H, Sekido Y, Kondo Y. Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells. J Biol Chem 2012;287:27396-406. [PMID: 22736761 DOI: 10.1074/jbc.M112.359109] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
73 Hu J, Markowitz G, Wang X. Isolation of Glioma-Initiating Cells for Biological Study. In: Koumenis C, Coussens LM, Giaccia A, Hammond E, editors. Tumor Microenvironment. Cham: Springer International Publishing; 2016. pp. 197-209. [DOI: 10.1007/978-3-319-26666-4_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Degrauwe N, Schlumpf TB, Janiszewska M, Martin P, Cauderay A, Provero P, Riggi N, Suvà ML, Paro R, Stamenkovic I. The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing. Cell Rep 2016;15:1634-47. [PMID: 27184842 DOI: 10.1016/j.celrep.2016.04.086] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
75 Beier CP, Kumar P, Meyer K, Leukel P, Bruttel V, Aschenbrenner I, Riemenschneider MJ, Fragoulis A, Rümmele P, Lamszus K, Schulz JB, Weis J, Bogdahn U, Wischhusen J, Hau P, Spang R, Beier D. The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev 2012;21:2753-61. [PMID: 22676416 DOI: 10.1089/scd.2011.0660] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
76 Wang LQ, Chim CS. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics 2015;7:461-73. [PMID: 25650645 DOI: 10.2217/epi.15.6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
77 Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CS. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. Mol Cancer 2013;12:173. [PMID: 24373626 DOI: 10.1186/1476-4598-12-173] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
78 Huang T, Alvarez A, Hu B, Cheng SY. Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer 2013;32:582-93. [PMID: 24206916 DOI: 10.5732/cjc.013.10170] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 10.9] [Reference Citation Analysis]
79 Riehmer V, Gietzelt J, Beyer U, Hentschel B, Westphal M, Schackert G, Sabel MC, Radlwimmer B, Pietsch T, Reifenberger G, Weller M, Weber RG, Loeffler M; German Glioma Network. Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. Genes Chromosomes Cancer 2014;53:589-605. [PMID: 24706357 DOI: 10.1002/gcc.22169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
80 Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, Verma M, Kumar D. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 2016;5:1917-46. [PMID: 27282910 DOI: 10.1002/cam4.775] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 17.0] [Reference Citation Analysis]
81 Behnan J, Isakson P, Joel M, Cilio C, Langmoen IA, Vik-Mo EO, Badn W. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells 2014;32:1110-23. [PMID: 24302539 DOI: 10.1002/stem.1614] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 7.8] [Reference Citation Analysis]
82 Nishioka C, Ikezoe T, Pan B, Xu K, Yokoyama A. MicroRNA-9 plays a role in interleukin-10-mediated expression of E-cadherin in acute myelogenous leukemia cells. Cancer Sci 2017;108:685-95. [PMID: 28107581 DOI: 10.1111/cas.13170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
83 Baronchelli S, Bentivegna A, Redaelli S, Riva G, Butta V, Paoletta L, Isimbaldi G, Miozzo M, Tabano S, Daga A, Marubbi D, Cattaneo M, Biunno I, Dalprà L. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One 2013;8:e57462. [PMID: 23468990 DOI: 10.1371/journal.pone.0057462] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
84 Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, Li J, Zhao Z. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. Int J Cancer 2014;135:1019-27. [PMID: 24500893 DOI: 10.1002/ijc.28761] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
85 Kim DC, Kim YZ. Analysis of microRNA expression in glial tumors by using a peptide nucleic acid-based microarray. Precis Future Med 2019;3:124-34. [DOI: 10.23838/pfm.2019.00044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Catuogno S, Esposito CL, Quintavalle C, Condorelli G, de Franciscis V, Cerchia L. Nucleic acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 2012;2012:735135. [PMID: 22685651 DOI: 10.1155/2012/735135] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
87 Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A. Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells 2015; 7(9): 1150-1184 [PMID: 26516408 DOI: 10.4252/wjsc.v7.i9.1150] [Cited by in F6Publishing: 88] [Reference Citation Analysis]
88 Zhang HH, Gu GL, Zhang XY, Li FZ, Ding L, Fan Q, Wu R, Shi W, Wang XY, Chen L, Wei XM, Yuan XY. Primary analysis and screening of microRNAs in gastric cancer side population cells. World J Gastroenterol 2015; 21(12): 3519-3526 [PMID: 25834316 DOI: 10.3748/wjg.v21.i12.3519] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
89 Lim CX, Lee B, Geiger O, Passegger C, Beitzinger M, Romberger J, Stracke A, Högenauer C, Stift A, Stoiber H, Poidinger M, Zebisch A, Meister G, Williams A, Flavell RA, Henao-Mejia J, Strobl H. miR-181a Modulation of ERK-MAPK Signaling Sustains DC-SIGN Expression and Limits Activation of Monocyte-Derived Dendritic Cells. Cell Rep 2020;30:3793-3805.e5. [PMID: 32187550 DOI: 10.1016/j.celrep.2020.02.077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Ahir BK, Ozer H, Engelhard HH, Lakka SS. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Crit Rev Oncol Hematol 2017;120:22-33. [PMID: 29198335 DOI: 10.1016/j.critrevonc.2017.10.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 11.2] [Reference Citation Analysis]
91 Chan XH, Nama S, Gopal F, Rizk P, Ramasamy S, Sundaram G, Ow GS, Ivshina AV, Tanavde V, Haybaeck J, Kuznetsov V, Sampath P. Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas. Cell Rep 2012;2:591-602. [PMID: 22921398 DOI: 10.1016/j.celrep.2012.07.012] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 6.5] [Reference Citation Analysis]
92 Marziali G, Buccarelli M, Giuliani A, Ilari R, Grande S, Palma A, D'Alessandris QG, Martini M, Biffoni M, Pallini R, Ricci-Vitiani L. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Mol Oncol 2017;11:1115-29. [PMID: 28248456 DOI: 10.1002/1878-0261.12047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
93 Zhao S, Liu H, Liu Y, Wu J, Wang C, Hou X, Chen X, Yang G, Zhao L, Che H, Bi Y, Wang H, Peng F, Ai J. miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. Cancer Letters 2013;333:253-60. [DOI: 10.1016/j.canlet.2013.01.039] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
94 Gao F, Zhao ZL, Zhao WT, Fan QR, Wang SC, Li J, Zhang YQ, Shi JW, Lin XL, Yang S. miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2013;431:610-616. [PMID: 23291181 DOI: 10.1016/j.bbrc.2012.12.097] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 9.1] [Reference Citation Analysis]
95 Jacobs EZ, Brown K, Byler MC, D'haenens E, Dheedene A, Henderson LB, Humberson JB, van Jaarsveld RH, Kanani F, Lebel RR, Millan F, Oegema R, Oostra A, Parker MJ, Rhodes L, Saenz M, Seaver LH, Si Y, Vanlander A, Vergult S, Callewaert B. Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants. Clin Genet 2021;99:259-68. [PMID: 33131045 DOI: 10.1111/cge.13874] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Sethi A, Sholl LM. Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells. Cancers (Basel). 2011;3:3957-3971. [PMID: 24213119 DOI: 10.3390/cancers3043957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
97 Nasr MA, Salah RA, Abd Elkodous M, Elshenawy SE, El-Badri N. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. Front Cell Dev Biol 2019;7:229. [PMID: 31681762 DOI: 10.3389/fcell.2019.00229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
98 Zhang HH, Gu GL, Zhang XY, Li FZ, Ding L, Fan Q, Wu R, Shi W, Wang XY, Chen L. Primary analysis and screening of microRNAs in gastric cancer side population cells. World J Gastroenterol. 2015;21:3519-3526. [PMID: 25834316 DOI: 10.3748/wjg.v21.i12. 3519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Chen X, Yang F, Zhang T, Wang W, Xi W, Li Y, Zhang D, Huo Y, Zhang J, Yang A, Wang T. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma. J Exp Clin Cancer Res 2019;38:99. [PMID: 30795814 DOI: 10.1186/s13046-019-1078-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
100 Song Y, Mu L, Han X, Li Q, Dong B, Li H, Liu X. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression. J Neurooncol 2013;115:381-90. [PMID: 24043603 DOI: 10.1007/s11060-013-1245-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
101 Munoz JL, Rodriguez-Cruz V, Walker ND, Greco SJ, Rameshwar P. Temozolomide resistance and tumor recurrence: Halting the Hedgehog. Cancer Cell Microenviron 2015;2:e747. [PMID: 27158638 DOI: 10.14800/ccm.747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
102 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
103 Zhao B, Bian EB, Li J, Li J. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs. J Cell Physiol 2014;229:1141-7. [PMID: 24374932 DOI: 10.1002/jcp.24540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
104 Geraldo LHM, Garcia C, da Fonseca ACC, Dubois LGF, de Sampaio e Spohr TCL, Matias D, de Camargo Magalhães ES, do Amaral RF, da Rosa BG, Grimaldi I, Leser FS, Janeiro JM, Macharia L, Wanjiru C, Pereira CM, Moura-neto V, Freitas C, Lima FRS. Glioblastoma Therapy in the Age of Molecular Medicine. Trends in Cancer 2019;5:46-65. [DOI: 10.1016/j.trecan.2018.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
105 Rosenberg T, Thomassen M, Jensen SS, Larsen MJ, Sørensen KP, Hermansen SK, Kruse TA, Kristensen BW. Acute hypoxia induces upregulation of microRNA-210 expression in glioblastoma spheroids. CNS Oncol. 2015;4:25-35. [PMID: 25586423 DOI: 10.2217/cns.14.48] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
106 Long C, Grueter CE, Song K, Qin S, Qi X, Kong YM, Shelton JM, Richardson JA, Zhang CL, Bassel-Duby R, Olson EN. Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor. Proc Natl Acad Sci U S A 2014;111:11521-6. [PMID: 25049392 DOI: 10.1073/pnas.1411251111] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
107 Ding LJ, Li Y, Wang SD, Wang XS, Fang F, Wang WY, Lv P, Zhao DH, Wei F, Qi L. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1. Int J Mol Sci 2016;17:E1617. [PMID: 27669232 DOI: 10.3390/ijms17101617] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
108 Blaylock RL. Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control. Surg Neurol Int 2015;6:92. [PMID: 26097771 DOI: 10.4103/2152-7806.157890] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
109 Chen X, Guo Z, Fan S, Sun L, Li H, Zhou J, Li Y. Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia. Pathol Res Pract 2019;215:152494. [PMID: 31229277 DOI: 10.1016/j.prp.2019.152494] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]